These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

601 related items for PubMed ID: 14660133

  • 21. Antagonist-precipitated heroin withdrawal under anaesthetic prior to maintenance naltrexone treatment: determinants of withdrawal severity.
    Ali R, Thomas P, White J, McGregor C, Danz C, Gowing L, Stegink A, Athanasos P.
    Drug Alcohol Rev; 2003 Dec; 22(4):425-31. PubMed ID: 14660132
    [Abstract] [Full Text] [Related]

  • 22. Challenges to antagonist blockade during sustained-release naltrexone treatment.
    Kunøe N, Lobmaier P, Vederhus JK, Hjerkinn B, Gossop M, Hegstad S, Kristensen Ø, Waal H.
    Addiction; 2010 Sep; 105(9):1633-9. PubMed ID: 20707781
    [Abstract] [Full Text] [Related]

  • 23. Public policy statement on buprenorphine for opiate dependence and withdrawal.
    J Addict Dis; 2004 Sep; 23(4):116-7. PubMed ID: 15534969
    [No Abstract] [Full Text] [Related]

  • 24. Heroin detoxification with a single high dose of buprenorphine.
    Kutz I, Reznik V.
    Isr J Psychiatry Relat Sci; 2002 Sep; 39(2):113-9. PubMed ID: 12227226
    [Abstract] [Full Text] [Related]

  • 25. [Buprenorphine as a new alternative for detoxification of heroin addicts. It causes only mild withdrawal problems, abating quickly].
    Blennow G, Fergusson A, Medvedeo A.
    Lakartidningen; 2000 Apr 12; 97(15):1830-3. PubMed ID: 10815411
    [Abstract] [Full Text] [Related]

  • 26. Ultra-rapid opiate detoxification: from clinical applications to basic science.
    Streel E, Verbanck P.
    Addict Biol; 2003 Jun 12; 8(2):141-6. PubMed ID: 12850772
    [Abstract] [Full Text] [Related]

  • 27. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial.
    Collins ED, Kleber HD, Whittington RA, Heitler NE.
    JAMA; 2005 Aug 24; 294(8):903-13. PubMed ID: 16118380
    [Abstract] [Full Text] [Related]

  • 28. [Drug therapy of opioid withdrawal].
    Cortese S, Risso M.
    Vertex; 2008 Aug 24; 19(77):522-6. PubMed ID: 18443666
    [Abstract] [Full Text] [Related]

  • 29. Antagonist treatment of opioid withdrawal translational low dose approach.
    Mannelli P, Gottheil E, Van Bockstaele EJ.
    J Addict Dis; 2006 Aug 24; 25(2):1-8. PubMed ID: 16785213
    [Abstract] [Full Text] [Related]

  • 30. Chronic very low dose naltrexone administration attenuates opioid withdrawal expression.
    Mannelli P, Gottheil E, Peoples JF, Oropeza VC, Van Bockstaele EJ.
    Biol Psychiatry; 2004 Aug 15; 56(4):261-8. PubMed ID: 15312814
    [Abstract] [Full Text] [Related]

  • 31. Effect of ultra-rapid opiate detoxification on withdrawal syndrome.
    Safari F, Mottaghi K, Malek S, Salimi A.
    J Addict Dis; 2010 Oct 15; 29(4):449-54. PubMed ID: 20924880
    [Abstract] [Full Text] [Related]

  • 32. [Forced opioid detoxification under general anesthesia--a new challenge for anesthetists and intensive care physicians].
    Hensel M, Volk T, Kox WJ.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 May 15; 34(5):261-8. PubMed ID: 10372215
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of the use of buprenorphine for opioid withdrawal in an emergency department.
    Berg ML, Idrees U, Ding R, Nesbit SA, Liang HK, McCarthy ML.
    Drug Alcohol Depend; 2007 Jan 12; 86(2-3):239-44. PubMed ID: 16930865
    [Abstract] [Full Text] [Related]

  • 34. The place of detoxification in treatment of opioid dependence.
    Gowing LR, Ali RL.
    Curr Opin Psychiatry; 2006 May 12; 19(3):266-70. PubMed ID: 16612211
    [Abstract] [Full Text] [Related]

  • 35. Evaluation on drug dependence of buprenorphine.
    Liu ZM, Lü XX, Lian Z, Mu Y, Guo P, An X.
    Acta Pharmacol Sin; 2003 May 12; 24(5):448-52. PubMed ID: 12740181
    [Abstract] [Full Text] [Related]

  • 36. Induction of patients with moderately severe methadone dependence onto buprenorphine.
    Glasper A, Reed LJ, de Wet CJ, Gossop M, Bearn J.
    Addict Biol; 2005 Jun 12; 10(2):149-55. PubMed ID: 16191667
    [Abstract] [Full Text] [Related]

  • 37. Less pain, more gain: buprenorphine-naloxone and patient retention in treatment.
    Renzelli CM, Capretto NA.
    J Addict Dis; 2006 Jun 12; 25(3):97-104. PubMed ID: 16956874
    [Abstract] [Full Text] [Related]

  • 38. Current pharmacotherapies for opioid dependence.
    Kosten TR.
    Psychopharmacol Bull; 1990 Jun 12; 26(1):69-74. PubMed ID: 2196628
    [Abstract] [Full Text] [Related]

  • 39. Contemporary methods in pharmacotherapy in the opiate dependent treatment.
    Radomska M, Bisaga A, Popik P.
    Przegl Lek; 2000 Jun 12; 57(10):509-18. PubMed ID: 11199877
    [Abstract] [Full Text] [Related]

  • 40. [Maintenance treatment for opiate dependence at a naltrexone clinic].
    López-Ibor Aliño JJ, Pérez de los Cobos JC, Ochoa E, Hernández Herreros M.
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1990 Jun 12; 18(5):296-305. PubMed ID: 1963258
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.